GlassScriptPhysician profile
Jason B Holder
NPI 1790909950
$2,156.34
in general payments reported to CMS, 2019-2025
21 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.41 · 2021: $66.70 · 2023: $1,091 · 2024: $742 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,051 · Education: $18.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,050.75 |
| Education | $18.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $484.32 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.64 | 2021-2024 | Ofev |
| Stryker Corporation | $183.93 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Grifols USA, LLC | $150.56 | 2021-2023 | Prolastin-C Liquid |
| Astrazeneca Pharmaceuticals LP | $143.26 | 2023-2024 | Breztri, Fasenra, Airsupra |
| Electromed, INC. | $138.52 | 2023-2025 | Smartvest |
| Intuitive Surgical, INC. | $134.45 | 2024 | |
| Mylan Specialty L.P. | $132.35 | 2021-2023 | Yupelri |
| Mallinckrodt Hospital Products INC. | $119.66 | 2023 | Acthar |
| Baxter Healthcare | $80.30 | 2023 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Genzyme Corporation | $69.38 | 2023-2024 | |
| United Therapeutics Corporation | $50.57 | 2024 | Tyvaso |
| La Jolla Pharmaceutical Company | $44.87 | 2023 | Giapreza |
| Philips North America LLC | $40.11 | 2024 | (Ak6) Vest Therapy |
| Shionogi INC | $33.47 | 2023 | Fetroja |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $30.91 | 2023 | Glassia |
| Inari Medical, INC. | $30.68 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merck Sharp & Dohme LLC | $20.17 | 2023 | |
| Amgen INC. | $18.48 | 2023 | Tavneos |
| Inogen, INC. | $14.99 | 2024 | |
| Janssen Pharmaceuticals, INC | $13.72 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Holder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.